Global Japanese Encephalitis Inactivated Vaccine Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Japanese Encephalitis Inactivated Vaccine players cover Valneva, Sanofi Pasteur, Biken, Lanzhou Institute of Biological Products Co., Ltd and Liaoning Chengda Biological Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Japanese Encephalitis Inactivated Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Japanese Encephalitis Inactivated Vaccine market, with both quantitative and qualitative data, to help readers understand how the Japanese Encephalitis Inactivated Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Japanese Encephalitis Inactivated Vaccine market and forecasts the market size by Type (Adult and Child,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Japanese Encephalitis Inactivated Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Japanese Encephalitis Inactivated Vaccine market size (sales and revenue) and CAGR, Japanese Encephalitis Inactivated Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Japanese Encephalitis Inactivated Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Japanese Encephalitis Inactivated Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Japanese Encephalitis Inactivated Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Valneva, Sanofi Pasteur, Biken, Lanzhou Institute of Biological Products Co., Ltd, Liaoning Chengda Biological Co., Ltd, Beijing Institute of Biological Products Co., Ltd and Chengdu Institute of Biological Products Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
The global market for Japanese Encephalitis Inactivated Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Japanese Encephalitis Inactivated Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Japanese Encephalitis Inactivated Vaccine players cover Valneva, Sanofi Pasteur, Biken, Lanzhou Institute of Biological Products Co., Ltd and Liaoning Chengda Biological Co., Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Japanese Encephalitis Inactivated Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Japanese Encephalitis Inactivated Vaccine market, with both quantitative and qualitative data, to help readers understand how the Japanese Encephalitis Inactivated Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Japanese Encephalitis Inactivated Vaccine market and forecasts the market size by Type (Adult and Child,), by Application (Hospital and Clinic.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Adult
- Child
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Valneva
- Sanofi Pasteur
- Biken
- Lanzhou Institute of Biological Products Co., Ltd
- Liaoning Chengda Biological Co., Ltd
- Beijing Institute of Biological Products Co., Ltd
- Chengdu Institute of Biological Products Co., Ltd
Chapter 1: Scope of Japanese Encephalitis Inactivated Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Japanese Encephalitis Inactivated Vaccine market size (sales and revenue) and CAGR, Japanese Encephalitis Inactivated Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Japanese Encephalitis Inactivated Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Japanese Encephalitis Inactivated Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Japanese Encephalitis Inactivated Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Valneva, Sanofi Pasteur, Biken, Lanzhou Institute of Biological Products Co., Ltd, Liaoning Chengda Biological Co., Ltd, Beijing Institute of Biological Products Co., Ltd and Chengdu Institute of Biological Products Co., Ltd, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Japanese Encephalitis Inactivated Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Japanese Encephalitis Inactivated Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Japanese Encephalitis Inactivated Vaccine Segment by Type
2.2.1 Adult
2.2.2 Child
2.3 Japanese Encephalitis Inactivated Vaccine Sales by Type
2.3.1 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Type (2017-2022)
2.4 Japanese Encephalitis Inactivated Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Japanese Encephalitis Inactivated Vaccine Sales by Application
2.5.1 Global Japanese Encephalitis Inactivated Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Japanese Encephalitis Inactivated Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Application (2017-2022)
3 GLOBAL JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY COMPANY
3.1 Global Japanese Encephalitis Inactivated Vaccine Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Company (2020-2022)
3.2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Inactivated Vaccine Product Location Distribution
3.4.2 Players Japanese Encephalitis Inactivated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Inactivated Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Geographic Region
4.2 World Historic Japanese Encephalitis Inactivated Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Country/Region
4.3 Americas Japanese Encephalitis Inactivated Vaccine Sales Growth
4.4 APAC Japanese Encephalitis Inactivated Vaccine Sales Growth
4.5 Europe Japanese Encephalitis Inactivated Vaccine Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Inactivated Vaccine Sales by Country
5.1.1 Americas Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
5.1.2 Americas Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
5.2 Americas Japanese Encephalitis Inactivated Vaccine Sales by Type
5.3 Americas Japanese Encephalitis Inactivated Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Inactivated Vaccine Sales by Region
6.1.1 APAC Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022)
6.1.2 APAC Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022)
6.2 APAC Japanese Encephalitis Inactivated Vaccine Sales by Type
6.3 APAC Japanese Encephalitis Inactivated Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Inactivated Vaccine by Country
7.1.1 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
7.1.2 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
7.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Type
7.3 Europe Japanese Encephalitis Inactivated Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Inactivated Vaccine by Country
8.1.1 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Type
8.3 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine
10.3 Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
10.4 Industry Chain Structure of Japanese Encephalitis Inactivated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Inactivated Vaccine Distributors
11.3 Japanese Encephalitis Inactivated Vaccine Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Inactivated Vaccine Forecast by Region (2023-2028)
12.1.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Japanese Encephalitis Inactivated Vaccine Forecast by Type
12.7 Global Japanese Encephalitis Inactivated Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Valneva
13.1.1 Valneva Company Information
13.1.2 Valneva Japanese Encephalitis Inactivated Vaccine Product Offered
13.1.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Valneva Main Business Overview
13.1.5 Valneva Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Offered
13.2.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Biken
13.3.1 Biken Company Information
13.3.2 Biken Japanese Encephalitis Inactivated Vaccine Product Offered
13.3.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biken Main Business Overview
13.3.5 Biken Latest Developments
13.4 Lanzhou Institute of Biological Products Co., Ltd
13.4.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
13.4.2 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.4.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute of Biological Products Co., Ltd Main Business Overview
13.4.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments
13.5 Liaoning Chengda Biological Co., Ltd
13.5.1 Liaoning Chengda Biological Co., Ltd Company Information
13.5.2 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.5.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Liaoning Chengda Biological Co., Ltd Main Business Overview
13.5.5 Liaoning Chengda Biological Co., Ltd Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd
13.6.1 Beijing Institute of Biological Products Co., Ltd Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.6.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing Institute of Biological Products Co., Ltd Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd Latest Developments
13.7 Chengdu Institute of Biological Products Co., Ltd
13.7.1 Chengdu Institute of Biological Products Co., Ltd Company Information
13.7.2 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.7.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chengdu Institute of Biological Products Co., Ltd Main Business Overview
13.7.5 Chengdu Institute of Biological Products Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Japanese Encephalitis Inactivated Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Japanese Encephalitis Inactivated Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Japanese Encephalitis Inactivated Vaccine Segment by Type
2.2.1 Adult
2.2.2 Child
2.3 Japanese Encephalitis Inactivated Vaccine Sales by Type
2.3.1 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Type (2017-2022)
2.4 Japanese Encephalitis Inactivated Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Japanese Encephalitis Inactivated Vaccine Sales by Application
2.5.1 Global Japanese Encephalitis Inactivated Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Japanese Encephalitis Inactivated Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Application (2017-2022)
3 GLOBAL JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY COMPANY
3.1 Global Japanese Encephalitis Inactivated Vaccine Breakdown Data by Company
3.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Company (2020-2022)
3.2.2 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Japanese Encephalitis Inactivated Vaccine Sale Price by Company
3.4 Key Manufacturers Japanese Encephalitis Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Japanese Encephalitis Inactivated Vaccine Product Location Distribution
3.4.2 Players Japanese Encephalitis Inactivated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Japanese Encephalitis Inactivated Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Geographic Region
4.2 World Historic Japanese Encephalitis Inactivated Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Japanese Encephalitis Inactivated Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue by Country/Region
4.3 Americas Japanese Encephalitis Inactivated Vaccine Sales Growth
4.4 APAC Japanese Encephalitis Inactivated Vaccine Sales Growth
4.5 Europe Japanese Encephalitis Inactivated Vaccine Sales Growth
4.6 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Japanese Encephalitis Inactivated Vaccine Sales by Country
5.1.1 Americas Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
5.1.2 Americas Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
5.2 Americas Japanese Encephalitis Inactivated Vaccine Sales by Type
5.3 Americas Japanese Encephalitis Inactivated Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Japanese Encephalitis Inactivated Vaccine Sales by Region
6.1.1 APAC Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022)
6.1.2 APAC Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022)
6.2 APAC Japanese Encephalitis Inactivated Vaccine Sales by Type
6.3 APAC Japanese Encephalitis Inactivated Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Japanese Encephalitis Inactivated Vaccine by Country
7.1.1 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
7.1.2 Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
7.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Type
7.3 Europe Japanese Encephalitis Inactivated Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Japanese Encephalitis Inactivated Vaccine by Country
8.1.1 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Type
8.3 Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine
10.3 Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
10.4 Industry Chain Structure of Japanese Encephalitis Inactivated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Japanese Encephalitis Inactivated Vaccine Distributors
11.3 Japanese Encephalitis Inactivated Vaccine Customer
12 WORLD FORECAST REVIEW FOR JAPANESE ENCEPHALITIS INACTIVATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Japanese Encephalitis Inactivated Vaccine Market Size Forecast by Region
12.1.1 Global Japanese Encephalitis Inactivated Vaccine Forecast by Region (2023-2028)
12.1.2 Global Japanese Encephalitis Inactivated Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Japanese Encephalitis Inactivated Vaccine Forecast by Type
12.7 Global Japanese Encephalitis Inactivated Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Valneva
13.1.1 Valneva Company Information
13.1.2 Valneva Japanese Encephalitis Inactivated Vaccine Product Offered
13.1.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Valneva Main Business Overview
13.1.5 Valneva Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Offered
13.2.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Biken
13.3.1 Biken Company Information
13.3.2 Biken Japanese Encephalitis Inactivated Vaccine Product Offered
13.3.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biken Main Business Overview
13.3.5 Biken Latest Developments
13.4 Lanzhou Institute of Biological Products Co., Ltd
13.4.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
13.4.2 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.4.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute of Biological Products Co., Ltd Main Business Overview
13.4.5 Lanzhou Institute of Biological Products Co., Ltd Latest Developments
13.5 Liaoning Chengda Biological Co., Ltd
13.5.1 Liaoning Chengda Biological Co., Ltd Company Information
13.5.2 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.5.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Liaoning Chengda Biological Co., Ltd Main Business Overview
13.5.5 Liaoning Chengda Biological Co., Ltd Latest Developments
13.6 Beijing Institute of Biological Products Co., Ltd
13.6.1 Beijing Institute of Biological Products Co., Ltd Company Information
13.6.2 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.6.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beijing Institute of Biological Products Co., Ltd Main Business Overview
13.6.5 Beijing Institute of Biological Products Co., Ltd Latest Developments
13.7 Chengdu Institute of Biological Products Co., Ltd
13.7.1 Chengdu Institute of Biological Products Co., Ltd Company Information
13.7.2 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
13.7.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Chengdu Institute of Biological Products Co., Ltd Main Business Overview
13.7.5 Chengdu Institute of Biological Products Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Japanese Encephalitis Inactivated Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Japanese Encephalitis Inactivated Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Adult
Table 4. Major Players of Child
Table 5. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2017-2022)
Table 13. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Japanese Encephalitis Inactivated Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Japanese Encephalitis Inactivated Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Japanese Encephalitis Inactivated Vaccine Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Inactivated Vaccine Products Offered
Table 22. Japanese Encephalitis Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Japanese Encephalitis Inactivated Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Japanese Encephalitis Inactivated Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Japanese Encephalitis Inactivated Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Japanese Encephalitis Inactivated Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Inactivated Vaccine
Table 66. Key Market Challenges & Risks of Japanese Encephalitis Inactivated Vaccine
Table 67. Key Industry Trends of Japanese Encephalitis Inactivated Vaccine
Table 68. Japanese Encephalitis Inactivated Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Japanese Encephalitis Inactivated Vaccine Distributors List
Table 71. Japanese Encephalitis Inactivated Vaccine Customer List
Table 72. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Japanese Encephalitis Inactivated Vaccine Sales Market Forecast by Region
Table 74. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Japanese Encephalitis Inactivated Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Valneva Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Valneva Japanese Encephalitis Inactivated Vaccine Product Offered
Table 94. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Valneva Main Business
Table 96. Valneva Latest Developments
Table 97. Sanofi Pasteur Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Offered
Table 99. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Biken Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Biken Japanese Encephalitis Inactivated Vaccine Product Offered
Table 104. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biken Main Business
Table 106. Biken Latest Developments
Table 107. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 109. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lanzhou Institute of Biological Products Co., Ltd Main Business
Table 111. Lanzhou Institute of Biological Products Co., Ltd Latest Developments
Table 112. Liaoning Chengda Biological Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 114. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Liaoning Chengda Biological Co., Ltd Main Business
Table 116. Liaoning Chengda Biological Co., Ltd Latest Developments
Table 117. Beijing Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 119. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Beijing Institute of Biological Products Co., Ltd Main Business
Table 121. Beijing Institute of Biological Products Co., Ltd Latest Developments
Table 122. Chengdu Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 124. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Chengdu Institute of Biological Products Co., Ltd Main Business
Table 126. Chengdu Institute of Biological Products Co., Ltd Latest Developments
Table 1. Japanese Encephalitis Inactivated Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Japanese Encephalitis Inactivated Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Adult
Table 4. Major Players of Child
Table 5. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2017-2022)
Table 13. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Japanese Encephalitis Inactivated Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Japanese Encephalitis Inactivated Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Japanese Encephalitis Inactivated Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Japanese Encephalitis Inactivated Vaccine Producing Area Distribution and Sales Area
Table 21. Players Japanese Encephalitis Inactivated Vaccine Products Offered
Table 22. Japanese Encephalitis Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Japanese Encephalitis Inactivated Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Japanese Encephalitis Inactivated Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Japanese Encephalitis Inactivated Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Japanese Encephalitis Inactivated Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Japanese Encephalitis Inactivated Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Japanese Encephalitis Inactivated Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Japanese Encephalitis Inactivated Vaccine
Table 66. Key Market Challenges & Risks of Japanese Encephalitis Inactivated Vaccine
Table 67. Key Industry Trends of Japanese Encephalitis Inactivated Vaccine
Table 68. Japanese Encephalitis Inactivated Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Japanese Encephalitis Inactivated Vaccine Distributors List
Table 71. Japanese Encephalitis Inactivated Vaccine Customer List
Table 72. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Japanese Encephalitis Inactivated Vaccine Sales Market Forecast by Region
Table 74. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Japanese Encephalitis Inactivated Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Japanese Encephalitis Inactivated Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Japanese Encephalitis Inactivated Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Valneva Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Valneva Japanese Encephalitis Inactivated Vaccine Product Offered
Table 94. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Valneva Main Business
Table 96. Valneva Latest Developments
Table 97. Sanofi Pasteur Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Offered
Table 99. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Biken Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Biken Japanese Encephalitis Inactivated Vaccine Product Offered
Table 104. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Biken Main Business
Table 106. Biken Latest Developments
Table 107. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 109. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lanzhou Institute of Biological Products Co., Ltd Main Business
Table 111. Lanzhou Institute of Biological Products Co., Ltd Latest Developments
Table 112. Liaoning Chengda Biological Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 114. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Liaoning Chengda Biological Co., Ltd Main Business
Table 116. Liaoning Chengda Biological Co., Ltd Latest Developments
Table 117. Beijing Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 119. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Beijing Institute of Biological Products Co., Ltd Main Business
Table 121. Beijing Institute of Biological Products Co., Ltd Latest Developments
Table 122. Chengdu Institute of Biological Products Co., Ltd Basic Information, Japanese Encephalitis Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Offered
Table 124. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Chengdu Institute of Biological Products Co., Ltd Main Business
Table 126. Chengdu Institute of Biological Products Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Japanese Encephalitis Inactivated Vaccine
Figure 2. Japanese Encephalitis Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Inactivated Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Japanese Encephalitis Inactivated Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Adult
Figure 10. Product Picture of Child
Figure 11. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type in 2021
Figure 12. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Japanese Encephalitis Inactivated Vaccine Consumed in Hospital
Figure 14. Global Japanese Encephalitis Inactivated Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Japanese Encephalitis Inactivated Vaccine Consumed in Clinic
Figure 16. Global Japanese Encephalitis Inactivated Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application in 2021
Figure 19. Japanese Encephalitis Inactivated Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
Figure 63. Industry Chain Structure of Japanese Encephalitis Inactivated Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 1. Picture of Japanese Encephalitis Inactivated Vaccine
Figure 2. Japanese Encephalitis Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Japanese Encephalitis Inactivated Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Japanese Encephalitis Inactivated Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Japanese Encephalitis Inactivated Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Adult
Figure 10. Product Picture of Child
Figure 11. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type in 2021
Figure 12. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Japanese Encephalitis Inactivated Vaccine Consumed in Hospital
Figure 14. Global Japanese Encephalitis Inactivated Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 15. Japanese Encephalitis Inactivated Vaccine Consumed in Clinic
Figure 16. Global Japanese Encephalitis Inactivated Vaccine Market: Clinic (2017-2022) & (K Units)
Figure 17. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application in 2021
Figure 19. Japanese Encephalitis Inactivated Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Japanese Encephalitis Inactivated Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Japanese Encephalitis Inactivated Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Japanese Encephalitis Inactivated Vaccine
Figure 63. Industry Chain Structure of Japanese Encephalitis Inactivated Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
